Skip to main content
Premium Trial:

Request an Annual Quote

Greg Yap

Greg Yap is joining Menlo Ventures as a partner to lead investments in health, medical, and life science technologies. Yap was most recently an entrepreneur-in-residence at Illumina Ventures, where he focused on new genomics investments, and also co-founded and served as CEO of PyrAmes, a digital health company. Previously Yap was CEO and co-founder of protein analysis firm Biodesy. He has also held senior roles at Roche/Ventana and Affymetrix.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.